3002 HSN Code: Human & animal blood prepared

HSN Sub Chapter 3002 represents Human & animal blood prepared under GST classification. This code helps businesses identify Human & animal blood prepared correctly for billing, taxation, and trade purposes. With HSN Sub Chapter 3002, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import/export of Human & animal blood prepared.

Live Demo Available Today

Experience the power of Expert Accounting

Join our guided walkthrough to see how BUSY can transform your business operations.

Trusted by 6,00,000+ Users
4.6 Google Rating
+91
expand_more

* No credit card required

New GST Rate for HSN Code 3002

GST Rate for Human & animal blood prepared under HSN Code 3002. Understand current tax rates, exemptions, and legal classifications to ensure accurate billing and GST filing.

Chapter No

30

HSN Code

HSN Description

Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified

New GST Rate

5 %
Essential

Old GST Rate

12 %

Tariff HSN Codes under HSN Sub Chapter 3002

Following tariff HSN codes fall under Human & animal blood prepared.

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for diptheria

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for tetanus

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for rabies

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for snake venom

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : other

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : hemoglobin blood globulins and serum globulins

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : of human origin

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : other

Tariff HSN

Description

Malaria diagnostic test kits

Tariff HSN

Description

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For diphtheria

Tariff HSN

Description

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For tetanus

Tariff HSN

Description

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For rabies

Tariff HSN

Description

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For Snake venom

Tariff HSN

Description

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : antisera: Other

Tariff HSN

Description

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Tariff HSN

Description

Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Tariff HSN

Description

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale:

Tariff HSN

Description

Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale

Tariff HSN

Description

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, put up in measured doses or in forms or packings for retail sale

Tariff HSN

Description

Other

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for cholera and typhoid

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for hepatitis

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tetanus

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for polio

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tuberculosis

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for rabies

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for japanese encephalitis

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for whopping cough (pertusis)

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : other

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria, pertusis and tetanus (dpt)

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria and tetanus (dt)

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for measles, mumps and rubella (mmr)

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for typhoid-paratyphoid (tab) or typhoid- paratyphoid-cholera (tabc)

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : other

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for veterinary medicine

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Cholera and typhoid

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Hepatitis

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tetanus

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Polio

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tuberclosis

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Rabies

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Japanese encephalitis

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Whopping cough (pertussis)

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Other

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria, pertussis and tetanus (DPT)

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria and tetanus (DT)

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Measles, mumps and rubella (MMR)

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid (TAB)

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid-cholera (TABC)

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Other

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for veterinary medicine

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Cultures of micro-organisms (excluding yeast)

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Toxins

Tariff HSN

Description

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Other

Tariff HSN

Description

Cell cultures, whether or not modified: Cell therapy products

Tariff HSN

Description

Cell cultures, whether or not modified: Other

Tariff HSN

Description

Other : Human blood

Tariff HSN

Description

Other : Animal blood prepared for therapeutic, prophylactic or diagnostic uses

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : cultures of micro-organisms (excluding yeast)

Tariff HSN

Description

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : toxins

Tariff HSN

Description

Other : Other

India’s Trade Performance — HSN Sub-Chapter 3002 in FY 2024-25

TradeStat EIDB — Ministry of Commerce & Industry FY 2018-19–FY 2024-25 Values in ₹ Crore

India’s Exports

FY 2024-25

₹15,063 Cr

+8.12% vs FY 2023-24

0.4067% of India’s total exports

India’s Imports

FY 2024-25

₹11,034 Cr

+29.28% vs FY 2023-24

0.1809% of India’s total imports

Trade Balance

FY 2024-25

₹4,029 Cr

Trade Surplus

Surplus rank #84 of 1233 subchapters

% of Chapter 30

FY 2024-25

7.24%

Share of Chapter 30’s total exports in FY 2024-25

Import side: 43.74% of Chapter 30’s imports

Rank Within Chapter 30

FY 2024-25

#2 of 6

Position by export value among subchapters in Chapter 30

Import-side rank: #1 of 6

At a glance

16.19%

Export CAGR

FY 2018-19 → FY 2024-25 · 7 fiscal years

#36

National Export Rank

of 1233 subchapters by export value, FY 2024-25

+21.85%

Peak Growth Year

FY 2020-21 · strongest single-year move

7.24%

Contribution to Ch. 30

Share of Chapter 30 exports in FY 2024-25

India Export-Import Trade Statistics for HSN Sub-Chapter 3002

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

FY 2018-19 Exp. Rank #67

Balance

+806.16

Exports

6,122.41 ₹ Cr

0.2667% share

YoY

5.93% of Ch. 30

Imports

5,316.25 ₹ Cr

0.1480% share

YoY

36.46% of Ch. 30

FY 2019-20 Exp. Rank #49

Balance

+576.12

Exports

7,453.44 ₹ Cr

0.3375% share

+21.74% YoY

6.45% of Ch. 30

Imports

6,877.32 ₹ Cr

0.2050% share

+29.36% YoY

41.60% of Ch. 30

FY 2020-21 Exp. Rank #38

Balance

+550.02

Exports

9,082.04 ₹ Cr

0.4223% share

+21.85% YoY

6.32% of Ch. 30

Imports

8,532.02 ₹ Cr

0.2928% share

+24.06% YoY

45.06% of Ch. 30

FY 2021-22 Exp. Rank #40

Balance

+1,805.52

Exports

10,918.65 ₹ Cr

0.3479% share

+20.22% YoY

7.55% of Ch. 30

Imports

9,113.13 ₹ Cr

0.1994% share

+6.81% YoY

35.59% of Ch. 30

FY 2022-23 Exp. Rank #43

Balance

+3,437.54

Exports

11,792.34 ₹ Cr

0.3257% share

+8.00% YoY

7.39% of Ch. 30

Imports

8,354.80 ₹ Cr

0.1453% share

−8.32% YoY

39.74% of Ch. 30

FY 2023-24 Exp. Rank #38

Balance

+5,396.20

Exports

13,931.50 ₹ Cr

0.3850% share

+18.14% YoY

7.61% of Ch. 30

Imports

8,535.30 ₹ Cr

0.1520% share

+2.16% YoY

39.88% of Ch. 30

FY 2024-25 Exp. Rank #36

Balance

+4,028.76

Exports

15,063.17 ₹ Cr

0.4067% share

+8.12% YoY

7.24% of Ch. 30

Imports

11,034.41 ₹ Cr

0.1809% share

+29.28% YoY

43.74% of Ch. 30

CAGR · 7-Year

Exports

16.19% /yr

Imports

12.94% /yr

Consistently Surplus
Chapter 30 total

reference, FY 2024-25

Export

₹2,08,128.62 Cr

Import

₹25,224.54 Cr

Trade Balance

+1,82,904.08

Peak export growth year Latest available data Not available YoY = change vs previous FY

Key Trade Insights: HSN Sub-Chapter 3002 Export-Import Analysis

Consistent Export Growth: 16.19% CAGR Over 7 Years

India's exports under HSN Sub-Chapter 3002 have grown at a compound annual rate of 16.19% over 7 fiscal years, rising from ₹6,122.41 Crore in FY 2018-19 to ₹15,063.17 Crore in FY 2024-25.

HSN Sub-Chapter 3002 Ranked #36 Among All 1233 Subchapters by Export Value

In FY 2024-25, HSN Sub-Chapter 3002 ranks #36 out of 1233 subchapters by total export value. Within Chapter 30, it ranks #2 of 6. By trade surplus, it ranks #84 of 1233.

FY 2020-21 Was the Strongest Growth Year for HSN Sub-Chapter 3002 Exports

The strongest single-year export movement for HSN Sub-Chapter 3002 was recorded in FY 2020-21, when exports surged by 21.85% over the prior year.

India Maintains a Trade Surplus of ₹4,028.76 Crore in HSN Sub-Chapter 3002 Goods

In FY 2024-25, India's exports of ₹15,063.17 Cr exceeded imports of ₹11,034.41 Cr, resulting in a trade surplus of ₹4,028.76 Crore — ranking #84 of 1233 by surplus magnitude.

Import Growth of 12.94% CAGR Signals Rising Demand for Human & animal blood prepared

India's imports under HSN Sub-Chapter 3002 have grown at 12.94% CAGR, reaching ₹11,034.41 Crore in FY 2024-25.

HSN Sub-Chapter 3002 Contributes 7.24% of Chapter 30 Exports — Ranked #2

Among the 6 subchapters under Chapter 30, HSN Sub-Chapter 3002 ranks #2 by export value — accounting for 7.24% of the chapter's total exports in FY 2024-25. On the import side, it holds 43.74% share (rank #1).

Stop worrying about HSN & TAX compliance

BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.

Automatic Updates
Error-free GSTR
6,00,000+ Happy Users
+91
expand_more

* No credit card required

Frequently Asked Questions

Clear answers to common queries about HSN Sub Chapter 3002 and GST compliance.

What products are classified under HSN 3002

It includes Human & animal blood prepared

How do I bill a kit or combo that includes Human & animal blood prepared?

Prefer separate lines per item with its HSN so each component follows its own tax treatment. If it is a naturally bundled supply, identify the principal supply and tax the whole bundle accordingly.

Do spares or accessories of Human & animal blood prepared follow the same HSN?

Not always. Spares are often classified by their own description or by the function/part rule. Check if a specific sub‑heading exists for parts of the main item and describe the part on the invoice.

If I repair and return Human & animal blood prepared, how should I charge GST?

Repair/service is a service supply (SAC). Parts and materials used are goods and may be billed separately with HSN. Mention both lines clearly to avoid mixing service and goods values.

Does MRP, weight or pack size change GST treatment for Human & animal blood prepared?

Some entries use MRP/weight‑based conditions for classification. Keep pack size, retail marking and brand status on records and invoice to support the chosen HSN.

Can I claim ITC on inputs and services used for Human & animal blood prepared?

If your outward supply of Human & animal blood prepared is taxable, ITC is generally available (Sections 16–17) except blocked credits (e.g., personal use, motor vehicles in most cases). For exempt supplies, proportionate reversal is required under Rule 42/43.

Important Disclaimer

The above does not constitute professional advice or a formal recommendation. We recommend consulting a professional tax consultant before acting on the information contained in this piece of content.

Explore More HSN Codes from Chapter 30